Marta
Santisteban Eslava
Consultora Médica
Hospital Universitario 12 de Octubre
Madrid, EspañaPublicacións en colaboración con investigadores/as de Hospital Universitario 12 de Octubre (5)
2021
-
Body shape trajectories and risk of breast cancer: Results from the SUN ('Seguimiento Universidad de Navarra') Project
Public Health Nutrition, Vol. 24, Núm. 3, pp. 467-475
-
Final results from the PERUSE study of first-line pertuzumab plus trastuzumab plus a taxane for HER2-positive locally recurrent or metastatic breast cancer, with a multivariable approach to guide prognostication
Annals of Oncology, Vol. 32, Núm. 10, pp. 1245-1255
-
Leisure-time physical activity, sedentary behavior, and risk of breast cancer: Results from the SUN (‘Seguimiento Universidad De Navarra’) project
Preventive Medicine, Vol. 148
2020
-
A retrospective, multicenter study of the efficacy of lapatinib plus trastuzumab in HER2-positive metastatic breast cancer patients previously treated with trastuzumab, lapatinib, or both: the Trastyvere study
Clinical and Translational Oncology, Vol. 22, Núm. 3, pp. 420-428
-
Real-world effectiveness of dual HER2 blockade with pertuzumab and trastuzumab for neoadjuvant treatment of HER2-positive early breast cancer (The NEOPETRA Study)
Breast Cancer Research and Treatment, Vol. 184, Núm. 2, pp. 469-479